BioSpace News Archive

Deals

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 17, 2024

Seres Therapeutics, Inc. today announced that on January 10, 2024, the Compensation and Talent Committee of Seres’ board of directors granted inducement equity grants covering an aggregate of 67,500 shares of its common stock to one new employee.

January 17, 2024
·
1 min read
BioMidwest

Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform

Cleveland Diagnostics, Inc. announced the closing of over $75M in growth capital financing.

January 17, 2024
·
4 min read
ZyVersa Therapeutics Highlights Peer-Reviewed Article Linking Inflammasome Activation to Triple-Negative Breast Cancer Brain Metastasis

ZyVersa announces publication of an article in the peer-reviewed journal, Acta Neuropathologica Communications, demonstrating that inflammasome activation enhances cancer metastasis to the brain in women with TNBC.

January 17, 2024
·
6 min read
Genetown

Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®

Gamida Cell Ltd. today announced it will present new data on its FDA approved allogeneic stem cell therapy Omisirge at the 2024 Tandem Meetings, Transplantation & Cellular Therapy (TCT) Meetings.

January 17, 2024
·
11 min read
Biotech Beach

Daré Bioscience Announces Grant to Support Biotherapeutic Product Development

Daré Bioscience, Inc. today announced it has received a grant from the Bill & Melinda Gates Foundation (the foundation) of $750,000 to fund activities related to bacteria-based live biotherapeutic product development.

January 17, 2024
·
8 min read
Business

Myomo Reports Preliminary Fourth Quarter Revenue and Backlog

Myomo, Inc. today announced preliminary revenue and operating metrics for the fourth quarter of 2023. Revenue for the fourth quarter of 2023 is expected to be in the range of $4.6 million to $4.8 million, an increase of 14% to 19%, compared with the same period a yea

January 17, 2024
·
5 min read
BioMidwest

New Intermediate Nail and RC Lag Screw Expand Gamma4 Portfolio to Meet the Needs of Surgeons and Their Patients

Stryker (NYSE: SYK), one of the world’s leading medical technologies companies, has expanded its Gamma4 Hip Fracture Nailing System, with the addition of an intermediate nail, the RC Lag Screw, and an anti-rotation clip with sleeve components.

January 17, 2024
·
4 min read
Business

Psycheceutical Bioscience Strategically Pivots Into the Brain-Computer Interface (BCI) Space

Psycheceutical Bioscience, Inc. appointed Neilank K. Jha, MD, Executive Chairman and CEO on November 1, 2023 to initiate an immediate turnaround to avert restructuring for operational, financial and regulatory reasons.

January 17, 2024
·
6 min read
Biotech Bay

Guardant Health to present data at ASCO GI supporting use of liquid biopsy to predict colon cancer recurrence

Guardant Health, Inc. will present interim data from the COSMOS study supporting the use of Guardant Reveal to predict disease recurrence in patients with early-stage colon cancer at the ASCO 2024 Gastrointestinal Cancers Symposium, January 18-20 in San Francisco.

January 17, 2024
·
5 min read
Biotech Beach

Thermo Fisher Scientific Unveils Industry’s First Off-the-Shelf Validated Software Solution to Automate Cell Therapy Manufacturing Workflows

Thermo Fisher Scientific today announced the launch of the Gibco™ Cell Therapy Systems (CTS™) Cellmation™ Software , a first-of-its-kind automation solution designed to connect and integrate workflows across multiple Thermo Fisher Scientific cell therapy instruments while enabling cGMP compliance.

January 17, 2024
·
3 min read